MedPath

CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation

Conditions
Chronic Thromboembolic Pulmonary Hypertension
Pulmonary Embolism
Registration Number
NCT04681014
Lead Sponsor
iPHNET (italian Pulmonary Hypertension NETwork)
Brief Summary

CTEPH-SOLUTION aims to create a risk score for the early detection of Chronic Thrombo-Embolic Pulmonary Hypertension (CTEPH) among patients with previous pulmonary embolism.

The risk score, created on retrospective data, will be validated on newly diagnosed pulmonary embolism patients.

Detailed Description

CTEPH-SOLUTION is a multicenter observational cross-sectional and prospective study in patients with a prior and new diagnosis of pulmonary embolism.

Patients with prior pulmonary embolism will be screened at baseline with doppler echocardiography: an estimated sPAP ≥ 40 mmHg will be the indication for pulmonary hypertension detection. After 24 months from baseline, patients will be followed-up for CTEPH detection. CTEPH diagnosis will be carried out according to the current ESC/ERS guidelines.

Incident (pulmonary embolism episode at least three months before the baseline) and prevalent (pulmonary embolism episode) patients will be enrolled.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1218
Inclusion Criteria
  • Age ≥ 18 at baseline evaluation
  • Diagnosis of prior (> 30 days from pulmonary embolism onset) or new-onset pulmonary embolism, according to the ESC guidelines on the diagnosis and management of acute pulmonary embolism
Exclusion Criteria
  • patients without pulmonary embolism diagnosis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CTEPH-SOLUTION score24 months

The CTEPH-SOLUTION score will be created on retrospective parameters (i.e., demographic data, diagnostic and clinical information, risk factors, laboratories parameters) collected on pulmonary embolism patients.

The minimum and maximum values will be defined after the multivariate statistical analysis, and the risk factors analyzed a posteriori. Higher scores mean a worse outcome.

Secondary Outcome Measures
NameTimeMethod
The number of the subject with a diagnosis of CTEPH on the total number of subjects enrolled.24 months

Trial Locations

Locations (1)

Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences. AOU Policlinico Umberto I

🇮🇹

Rome, Italy

© Copyright 2025. All Rights Reserved by MedPath